Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients
- Conditions
- Tobacco Use Disorder
- Interventions
- Other: Combined intervention
- First Posted Date
- 2003-05-15
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 28
- Registration Number
- NCT00060814
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2003-01-20
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 24
- Registration Number
- NCT00051896
- Locations
- πΊπΈ
Uniformed Services University of Health Science, Bethesda, Maryland, United States
Chemical Dependency and Smoking Cessation: Patient's Views - 1
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 2003-01-20
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 125
- Registration Number
- NCT00051883
- Locations
- πΊπΈ
University of Kansas Medical Center, Kansas City, Kansas, United States
Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1
- Conditions
- Tobacco Use Disorder
- First Posted Date
- 2002-10-03
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 100
- Registration Number
- NCT00046813
- Locations
- πΊπΈ
UMDNJ - Robert Wood Johnson Medical School, Piscataway, New Jersey, United States
πΊπΈUMDNJ - Robert Wood Johnson Medical School-2, Piscataway, New Jersey, United States
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2002-06-18
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 32
- Registration Number
- NCT00040066
- Locations
- πΊπΈ
University of Texas Health Science Center, San Antonio, Texas, United States
πΊπΈUCLA Integrated Substance Abuse Program, Los Angeles, California, United States
Ondansetron for the Treatment of Methamphetamine Dependence - 1
- Conditions
- Amphetamine-Related Disorders
- First Posted Date
- 2002-06-18
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 154
- Registration Number
- NCT00040053
- Locations
- πΊπΈ
South Bay Treatment Center, Chula Vista, California, United States
πΊπΈJohn A. Burns School of Medicine, Honolulu, Hawaii, United States
πΊπΈPowell Chemical Dependency Center, Des Moines, Iowa, United States
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
- Conditions
- Amphetamine-Related Disorders
- First Posted Date
- 2002-06-18
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 20
- Registration Number
- NCT00040040
- Locations
- πΊπΈ
University of Texas Health Science Center, Houston, Texas, United States
πΊπΈUCLA Integrated Substance Abuse Program, Los Angeles, California, United States
Reserpine for the Treatment of Cocaine Dependence - 1
- Conditions
- Cocaine-Related DisordersSubstance-Related Disorders
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 140
- Registration Number
- NCT00033033
- Locations
- πΊπΈ
Cincinnati VA Medical Center, Cincinnati, Ohio, United States
πΊπΈDayton VA Medical Center, Dayton, Ohio, United States
πΊπΈBoston University Medical Center, Boston, Massachusetts, United States
Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 269
- Registration Number
- NCT00032929
- Locations
- πΊπΈ
Haight-Ashbury Free Clinic, Berkeley, California, United States
πΊπΈCincinnati VA Medical Center, Cincinnati, Ohio, United States
πΊπΈVA North Texas Health Care System, Dallas, Texas, United States
Lofexidine for Opiate Withdrawal - 1
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 66
- Registration Number
- NCT00032942
- Locations
- πΊπΈ
Philadelphia Veterans Medical Center, Philadelphia, Pennsylvania, United States
πΊπΈUCLA Medical Center, Los Angeles, California, United States
πΊπΈColumbia University, New York, New York, United States